Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain

Clinical trial NCT00020839 · TERMINATED

Trial details

NCT number: NCT00020839
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Melanoma (Skin)Metastatic Cancer

Start date: 2001-04-01
Primary completion: 2003-05-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.